TrialCancer chemotherapy and pharmacology2015

Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study.

Jaime R Merchan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.